A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Kaletra


WORLD NOTES  -  25 May 2007
People's Weekly WorldThailand stopped buying Efavirenz made by Merck Sharp and Dohme, and Kaletra made by Abbott Laboratories. On May 14, Brazil followed suit by announcing

WHO Urges Development of Cheap Drugs despite US Rejection  -  May 23, 2007
The Irrawaddy News Magazine,Kaletra, produced by US manufacturer Abott Laboratories, is one of the commonly used second-line drugs. But at a cost of about US $2200 per year,

Second-line drugs only hope for many  -  May 13, 2007
Bangkok Post,She is resistant to first-line drugs such as GPO-VIR and the second-line drug Kaletra seems to be the only hope for her. Fortunately, last March she was

Abbott in Thailand  -  May 10, 2007
Chicago Tribune,The company also cut the price of Kaletra to $1000 a year for some 40 other developing countries that are several steps up from the poorest.

Thailand Will Not Issue Compulsory Licenses for Patented Drugs  -  May 17, 2007
MedIndia,The Thai government in November 2006 and January issued compulsory licenses to produce lower-cost versions of Merck's antiretroviral Efavirenz and Kaletra,

Abbott Offers To Sell Antiretroviral Aluvia At Reduced Price In ...  -  May 17, 2007
Medical News Today (press release),Pharmaceutical company Abbott Laboratories has offered to sell its antiretroviral drug Aluvia, an updated version of its antiretroviral Kaletra,

Drug licensing 'gaining support'  -  May 14, 2007
Bangkok Post,In January, Thailand issued three more compulsory licenses for the heart disease drug Plavix, made by Sanofi-Aventis and Kaletra, another HIV/Aids drug

Thailand turns giant pharma killer  -  May 14, 2007
Asia Times Online,Thailand's clash with Abbott, which began in January after the government's issuing of a CL for the drug Kaletra, intensified in March when Abbott

US drug maker offers Thailand further  -  May 14, 2007
France24,The government here has jolted the powerful pharmaceutical industry by allowing generic versions of anti-AIDS drugs Kaletra and Efavirenz and popular heart

Cancer next priority in pharma war  -  May 15, 2007
Bangkok Post,Top of their agenda was Thailand's issuing compulsory licences to import or produce cheaper generic versions of the Aids drugs Efavirenz and Kaletra and the

Abbott dishonors Wisconsin Idea  -  May 6, 2007
UW Badger Herald,In situations where entire generations of African populations are being eliminated, Kaletra is more than just a significant drug — it is an essential one.

Talks fail on agreement to supply cheap drugs  -  May 14, 2007
Nation Multimedia,The ministry decided to invoke the process of compulsory licensing on Kaletra and Plavix so that it could ignore patents on them and legally import cheaper

Debate Over Thai Compulsory Licensing Will Undermine Drug ...  -  May 14, 2007
Kaiser network.org,Although pharmaceutical company Abbott Laboratories offers many of the world's poorest countries with a discounted price for its antiretroviral drug Kaletra

AIDS Healthcare Foundation Says CalPERS to Question Abbott on ...  -  Apr 26, 2007
PR Newswire (press release),Despite Kudos for Recent Offers of Price Cuts on Kaletra and Aluvia in Thailand and Other Lower Middle-income Countries, Nation's Largest Pension System to

Thai activists pressure Abbott  -  Apr 28, 2007
Waukegan News Sun,Medical students from the Chicago area protest in front of the Tribune Tower the recent action by Abbott Laboratories to remove their AIDS drug Kaletra and

Thailand slams US copyright report  -  May 2, 2007
France24,The government plans to import generic versions of AIDS drugs, Kaletra and Efavirenz, and popular heart disease medicine Plavix, from India.

Unfolding Tragedy: ‘The Balancing Act Between Innovation, Success’  -  May 1, 2007
MidwestBusiness.com,CHICAGO – Many people have been following with great interest the Abbott Laboratories story regarding its Kaletra AIDS drug and the conflict with the

Abbott vs. Thailand has implications for innovation and access  -  May 1, 2007
WTN News,Many of you have been following the Abbott Laboratories story regarding its Kaletra AIDS drug and the conflict with the government of Thailand over patent

Taking on the drug companies  -  Apr 27, 2007
Guardian Unlimited,First-line Aids drugs are becoming ineffective, as the virus becomes resistant, and so people need the expensive new drugs like Kaletra, made by the US drug

Students Protest Drug Policy  -  Apr 27, 2007
Harvard Crimson,In January, Thailand issued a “compulsory license� that would have allowed companies to produce generic versions of Kaletra and Aluvia, another AIDS drug,

Clinton Arranges Cheaper AIDS Drugs  -  May 10, 2007
International News Service,Abbott had been charging $2200 annually per patient for Kaletra in middle-income developing countries, which include India, China, Brazil and Ukraine.

Clinton backs violation of Aids drug patents  -  May 9, 2007
Guardian Unlimited,He said the move would cut the cost of the Aids drugs Kaletra and Aluvia to $695 per patient per year. This is significantly cheaper than the latest offer

Official: US ex-President Clinton supports Thailand's move to ...  -  May 8, 2007
International Herald Tribune,The minister was visiting the US to explain Thailand's decision to break patents on three AIDS-fighting drugs including Kaletra, produced by Abbott

Africa: Daily HIV/Aids Report  -  May 1, 2007
AllAfrica.com,The report did not mention any drugs by name but "appeared to be referring" to the compulsory licenses for Efavirenz and Kaletra, according to Reuters

Clinton Backs Violation of Aids Drug Patents  -  May 9, 2007
Buzzle,He said the move would cut the cost of the Aids drugs, Kaletra and Aluvia, to $695 per patient per year. This is significantly cheaper than the latest offer

AIDS controversy dominates Abbott Labs' annual meeting  -  Apr 27, 2007
Chicago Tribune,Early this year, Thailand said that it couldn't afford the price Abbott charges for Kaletra, and disclosed plans to issue what's known as a "compulsory

Protests outside drug company  -  Apr 26, 2007
Maidenhead Advertiser,Abbott say they do not deny access to life saving treatments and that Kaletra is available in 118 countries including Thailand.

Licence-busting 'will save B1.6 bln'  -  May 5, 2007
Bangkok Post,During the 2006 fiscal year, Thailand's NHSC bought 12000 bottles of the HIV drug Kaletra at the cost of 8900 baht per bottle and has projected purchase of

Thailand saves Bt1.6bn with compulsory licensing  -  May 5, 2007
Pattaya Daily News,During the 2006 fiscal year, Thailand's NHSC bought 12000 bottles of the HIV drug Kaletra at the cost of Bt8,900 per bottle and has projected purchase of

Big Pharma Goes After Generic AIDS Drugs in Thailand  -  May 3, 2007
Newsinferno.com,According to the Thai government, they have only issued compulsory licenses on three drugs, but two of the three are AIDS drugs: Abbott’s Kaletra and

AIDS Healthcare Foundation Says CalPERS to Question Abbott on ...  -  26 Apr 2007
Earthtimes.orgThree weeks ago, in response in part to worldwide outcry against Abbott, the company announced it would offer its key AIDS drug, Kaletra, to Thailand and 40

Brazil Moves to Break Merck's Patent AIDS Drug Use (Update1)  -  26 Apr 2007
BloombergIn 2005, the government signed an accord with Abbott Laboratories to cut the price of Kaletra by 46 percent. Brazil supplies drugs for free to as many as

Thailand Will Maintain Compulsory Licenses for Kaletra, Efavirenz ...  -  Apr 16, 2007
Kaiser network.org,Mongkol in January signed the compulsory license, which allows Thailand to produce a lower-cost version of Kaletra, into law. Abbott in March announced that

Abbott to offer new AIDS drug in Thailand  -  Apr 23, 2007
ReutersN: Quote, Profile, Research) to sell a newer form of its AIDS drug Kaletra at a discounted price, Health Minister Mongkol na Songkhla said on Monday.

Abbott to offer new AIDS drug in Thailand  -  Apr 23, 2007
Reuters AlertNet,BANGKOK, April 23 (Reuters) - Thailand is weighing an offer from Abbott Laboratories Inc. to sell a newer form of its AIDS drug Kaletra at a discounted

BUSINESS BRIEFS  -  Apr 23, 2007
The Brunei Times,BANGKOK: Thailand is weighing an offer from Abbott Laboratories Inc to sell a newer form of its Aids drug Kaletra at a discounted price, Health Minister

Abbott Agrees To Expand Access To Kaletra, Aluvia  -  Apr 10, 2007
eMaxHealth.com,Abbott and World Health Organization have agreed on a balanced approach to provide Kaletra/Aluvia capsules and tablets to more patients in the developing

Abbott Tries New Approach to Kaletra/Aluvia Pricing  -  Apr 12, 2007
Patent Baristas,Abbott and World Health Organization (WHO) Director-General, Margaret Chan, have agreed on a neew approach to provide Kaletra/Aluvia (lopinavir/ritonavir)

Abbott To Reduce Cost of Kaletra in Thailand, Other Developing ...  -  Apr 11, 2007
Kaiser network.org,Abbott Laboratories on Tuesday said that it plans to reduce the cost of its antiretroviral drug Kaletra in Thailand and more than 40 low- and

Abbott cuts price of AIDS drug Kaletra by 55 pct in poor countries  -  Apr 10, 2007
Forbes,CHICAGO (Thomson Financial) - Abbott Laboratories said it has agreed to more than halve the price of a key AIDS treatment Kaletra in more than 40 poor

Abbott slashes the price of AIDS drug Kaletra and waits for ...  -  Apr 11, 2007
Pharma Times (subscription),Abbott Laboratories has decided to cut the price of its AIDS drug Kaletra by more than half in some of the world's poorest countries in a move that is being

Abbott Bows to AIDS Activists on Kaletra Pricing, Says AIDS ...  -  Apr 10, 2007
PR Newswire UK (press release),With Abbott's offer, the price of Kaletra in Thailand will drop from roughly $2200US to approximately $1000US. AHF believes Abbott's move came in part from

Abbott Bows to AIDS Activists on Kaletra Pricing, Says AIDS ...  -  Apr 10, 2007
PR-Inside.com (Pressemitteilung),With Abbott's offer, the price of Kaletra in Thailand will drop from roughly $2200US to approximately $1000US. AHF believes Abbott's

Abbott announces Kaletra price cut for lower middle-income ...  -  Apr 10, 2007
Aidsmap,Abbott announced today that it will cut the price of Kaletra (lopinavir/ritonavir) in 40 lower middle-income countries to $1000 a year following discussions

Abbott to Offer New AIDS Drug in Thailand -WSJ  -  Apr 22, 2007
Reuters.uk,N: Quote, Profile , Research) is offering to sell a newer form of its AIDS drug Kaletra in Thailand at a discounted rate, the Wall Street Journal reported

Thailand Wins Concession on Drug  -  Apr 22, 2007
Wall Street Journal (subscription),Abbott is offering to sell the latest version of its AIDS drug Kaletra in Thailand at a discounted rate, according to Miles White, Abbott's chief executive.

Abbott makes AIDS drug offer to Thailand  -  Apr 23, 2007
Reuters.uk,It comes weeks after Abbott refused to launch Aluvia in Thailand to protest the government's January override of an international patent on Kaletra.

Abbott Offers To Sell New Antiretroviral Drug Aluvia in Thailand ...  -  Apr 23, 2007
Kaiser network.org,Aluvia is an updated version of Abbott's antiretroviral Kaletra (Zamiska/Hookway, Wall Street Journal , 4/23). Thailand's Ministry of Public Health last

The eight deadly lies of Big Pharma  -  Apr 20, 2007
Nation Multimedia,Lie No-1: Mellisa Brotz, a spokeswoman for Abbott Industries: "We do not view [the compulsory licence on Kaletra] legal or in the best interest of patients.

Abbott Agrees With World Health Organization (WHO) Director ...  -  Apr 11, 2007
Drug Newswire (press release),Today, Kaletra capsules are registered in 118 countries, making it the most widely registered HIV medicine. Kaletra/Aluvia tablets will be registered in

Africa: Daily HIV/Aids Report  -  Apr 16, 2007
AllAfrica.com,Thailand will maintain compulsory licenses for Abbott Laboratories' antiretroviral drug Kaletra and Merck's antiretroviral Efavirenz, despite both

Abbott Agrees With World Health Organization (WHO) Director ...  -  Apr 9, 2007
PR Newswire (press release),Meanwhile, Kaletra capsules remain available in Thailand and will be eligible for the new price. Today, Kaletra capsules are registered in 118 countries,

Govt seeking new generic imports  -  Apr 18, 2007
Bangkok Post,However, this improved version of Kaletra could be reduced to below 2000 baht to compete with the Kaletra price offered by Abbott.

Thailand’s Bittersweet Victory over Big Pharma  -  Apr 12, 2007
Asia Sentinel,The row started in January when Thailand announced it would issue a compulsory license for Kaletra, as it had previously done with other antiretrovirals and

Guyana accessing key HIV drug cheaply from US-based company -Ramsammy  -  Apr 12, 2007
Stabroek News,Kaletra capsules are registered in 118 countries, making it the most widely registered HIV medicine. Kaletra/Aluvia tablets will be registered in more than

Abbott agrees with WHO to expand access to lopinavir / ritonavir  -  Apr 11, 2007
News-Medical.net,Abbott and World Health Organization (WHO) Director-General, Margaret Chan, have agreed on a balanced approach to provide Kaletra/Aluvia

Thailand 'happy' with Abbott's price cut amid generic drug row  -  Apr 11, 2007
Nation Multimedia,Thailand's army-backed government has jolted the powerful pharmaceutical industry by allowing generic versions of Kaletra, another Aids drug Efavirenz,

Cost of new drugs must be stated  -  Apr 16, 2007
Bangkok Post,Abbott Laboratories, the patent holder of Kaletra, rejected the move by withholding a plan to introduce new drugs _ including Aluvia, which is an upgraded

Thailand Weighs Offer for AIDS Drugs  -  Apr 10, 2007
Sci-Tech TodayA new, lower-cost offer appeared to be a breakthrough in ending a dispute between Thailand and Abbott over the high price of Kaletra.

Speed of viral load decline is a sign of more effective ...  -  Apr 18, 2007
Aidsmap,The findings from ACTG A5095 have been reinforced by a recent analysis of the ACTG 5142 study, which compared efavirenz or Kaletra-based regimens with an

Abbott to cut AIDS drug cost in poor nations May avert showdown ...  -  Apr 11, 2007
Chicago Tribune,Moving to defuse a potentially damaging international controversy, Abbott Laboratories said Tuesday that it will cut the price of its AIDS-fighting Kaletra

Abbott Refuses Invitation for Second Round of Talks With Thai ...  -  Apr 10, 2007
Kaiser network.org,Thai Health Minister Mongkol Na Songkhla in January signed the compulsory license, which allows Thailand to produce a lower-cost version of Kaletra,

THAILAND: US firm cuts AIDS drug price - 13/04/2007  -  Apr 12, 2007
Radio Australia,The US pharmaceutical giant Abbott says it will cut the price of key AIDS drug Kaletra in 40 low and middle income countries.

Abbott to lower price of HIV drug  -  Apr 10, 2007
Pharmaceutical Business ReviewAbbott has said it has agreed with the World Health Organization to cut the price of its HIV drug Kaletra for patients in the developing world.

Thailand Takes on Drug Industry, and May Be Winning  -  Apr 12, 2007
International News Service,Abbott Laboratories, the maker of the AIDS drug Kaletra, took the radical step of withdrawing all of its new products from Thailand, depriving Thais of

Thailand Mulls Offer for Low-Cost AIDS Drugs  -  Apr 12, 2007
Sci-Tech TodayAbbott earlier Tuesday announced that after consulting with the UN's World Health Organization, it had decided to offer its drug Kaletra, also marketed

Abbott Bows, Cuts AIDS Drug Prices  -  Apr 11, 2007
Wall Street Journal (subscription),In a sign of compromise, Abbott Laboratories agreed to sell its AIDS medicine Kaletra to many developing nations at a price below generic versions.

Comment: Drug makers forced to swallow ...  -  Apr 13, 2007
New Straits Times,Abbott Laboratories, which makes the HIV drug Kaletra, took the radical step of withdrawing all its new products from the country, depriving Thais of access


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional